Potential New Fund Raising

RNS Number : 4579M

The MedicX Fund Limited

29 January 2009

 



For immediate release                                                                                                       29 January 2009

MedicX Fund Limited

('MedicX Fund', 'the Fund' or 'the Company')

Acquisition opportunities and potential new fund raising 

MedicX Fund Limited, (LSE: MXF) (the 'Company'), the specialist primary care infrastructure investor in modern, purpose built, primary healthcare properties in the United Kingdom, announces that it is considering raising additional monies by way of an equity issue.

The Company has considered the current market conditions within the primary care infrastructure sector, in particular the widening role of primary care and also the increasing role for the private sector, and has identified opportunities to acquire assets at attractive yields. With additional capital, the Company will be in a position to pursue these acquisition opportunities.

Further details will be announced in due course.

End

For further information please contact:

MedicX Fund                                                                  [phone]

David Staples, Chairman                     

MedicX Group                                                                 [phone]

Keith Maddin, Chairman

Mike Adams, Managing Director

Buchanan Communications                                               [phone]

Charles Ryland / Miranda Higham / Mary-Jane Johnson

Collins Stewart Europe Limited                                          [phone]

Robbie Robertson / Andrew Zychowski 

Important Information

This announcement and the information contained herein is restricted and is not for publication, release or distribution in whole or in part in the United States, Canada, Australia or Japan. 

This announcement does not constitute or form part of any offer or invitation to sell, or any solicitation of any offer to purchase, any securities of the Company and any purchase of securities of the Company pursuant to any equity issue undertaken by the Company should only be made on the basis of the information contained in the final prospectus to be published by the Company and any supplement or amendment thereto (the 'Prospectus'). When made generally available, copies of the Prospectus may, subject to any applicable law, be obtained at no cost at the registered office of the Company or from the Document Viewing Facility, UK Listing Authority, The Financial Services Authority, 25 North Colonnade, Canary Wharf, London E14 5HS. The Prospectus will supersede all information provided before the date of the Prospectus and any investment decision must be made only on the basis of the information contained therein.

The contents of this announcement have been prepared by and are the sole responsibility of the Company. Collins Stewart Europe Limited ('Collins Stewart') is acting exclusively for the Company and no one else in connection with the equity issue. Collins Stewart does not regard any other person (whether or not a recipient of this announcement) as its client in relation to the equity issue and will not be responsible to anyone other than the Company for providing the protections afforded to its clients nor for giving advice in relation to the content of this announcement or any transaction or other matter referred to herein.

 

END

 

 

MSCFKLFLKFBBBBZ